HANTAVIRUS
Información actualizada para la población general
Prevención, transmisión, síntomas y medidas de protección basadas en evidencia científica internacional
Actualizado 2026 | By DrRamonReyesMD ⚕️
🧬 ¿QUÉ ES EL HANTAVIRUS?
Los hantavirus son virus ARN pertenecientes a la familia Hantaviridae, transmitidos principalmente por roedores silvestres infectados.
Pueden provocar enfermedades humanas graves, especialmente:
- Síndrome Pulmonar por Hantavirus (SPH / HPS)
- Fiebre Hemorrágica con Síndrome Renal (FHSR / HFRS)
Estas enfermedades afectan principalmente:
- pulmones
- endotelio vascular
- riñones
- sistema cardiovascular
En casos graves pueden evolucionar rápidamente hacia:
- insuficiencia respiratoria aguda
- edema pulmonar no cardiogénico
- shock
- fallo multiorgánico
La Organización Mundial de la Salud (OMS) considera los hantavirus zoonosis emergentes de importancia internacional.
🌍 DISTRIBUCIÓN GLOBAL
Los hantavirus tienen distribución mundial.
Las formas clínicas predominantes varían según la región:
América
Predomina el:
- Síndrome Pulmonar por Hantavirus (HPS/SPH)
Relacionados con:
- virus Andes
- Sin Nombre virus
- Laguna Negra virus
- Choclo virus
Europa y Asia
Predomina:
- Fiebre Hemorrágica con Síndrome Renal (HFRS)
Relacionada con:
- Hantaan virus
- Puumala virus
- Dobrava-Belgrade virus
- Seoul virus
🐀 ¿CÓMO SE TRANSMITE?
La transmisión ocurre principalmente por inhalación de partículas contaminadas procedentes de:
- orina de roedores
- heces
- saliva
- polvo contaminado
El riesgo aumenta en:
- viviendas cerradas
- espacios poco ventilados
- graneros
- trasteros
- almacenes
- cabañas abandonadas
- áreas rurales infestadas de roedores
La evidencia científica internacional coincide en que:
La principal vía de contagio es ambiental y no interpersonal.
⚠️ ¿SE TRANSMITE ENTRE PERSONAS?
La transmisión entre personas es rara.
La mayoría de casos documentados en:
- América
- Europa
- Asia
están relacionados con exposición ambiental.
Sin embargo:
Virus Andes
El virus Andes, descrito principalmente en Sudamérica, ha demostrado casos limitados de:
- transmisión intrafamiliar
- transmisión por contacto estrecho prolongado
- transmisión nosocomial excepcional
Esto está ampliamente documentado en literatura científica.
🩺 SÍNTOMAS PRINCIPALES
La enfermedad puede comenzar como un cuadro pseudogripal:
- fiebre
- cefalea
- mialgias intensas
- escalofríos
- malestar general
- náuseas
- vómitos
- dolor abdominal
- diarrea
Posteriormente pueden aparecer:
- tos
- disnea
- hipoxemia
- edema pulmonar
- insuficiencia respiratoria
- shock
⏳ PERÍODO DE INCUBACIÓN
El período de incubación suele variar entre:
- 1 y 6 semanas
aunque puede variar según:
- carga viral
- variante específica
- vía de exposición
- susceptibilidad individual
⚠️ MORTALIDAD Y GRAVEDAD
El Síndrome Pulmonar por Hantavirus puede presentar mortalidad elevada.
Según CDC y literatura científica internacional:
- mortalidad aproximada del HPS: 30–40%
- algunos brotes sudamericanos han mostrado cifras superiores
La gravedad depende de:
- diagnóstico precoz
- acceso a UCI
- soporte ventilatorio avanzado
- carga viral
- estado inmunológico
- velocidad de progresión cardiopulmonar
🔬 FISIOPATOLOGÍA
Lesión endotelial
El hantavirus provoca:
- aumento de permeabilidad capilar
- fuga vascular sistémica
- edema pulmonar
- hipotensión
- hemoconcentración
Respuesta inmunológica
Gran parte del daño clínico es inmunomediado.
Existe:
- activación masiva inflamatoria
- liberación de citocinas
- disfunción vascular
similar a otros síndromes virales graves.
🛡️ PREVENCIÓN
1. Ventilar espacios cerrados
Antes de limpiar:
- abrir puertas y ventanas 20–30 minutos
- permitir recambio de aire
2. NO barrer en seco
Debe evitarse:
- barrer
- aspirar polvo seco
- sacudir telas contaminadas
porque pueden aerosolizar partículas virales.
3. Humedecer superficies antes de limpiar
Usar:
- desinfectantes
- soluciones con hipoclorito sódico (lejía)
El CDC recomienda desinfectar antes de manipular zonas contaminadas.
4. Uso de protección personal
En ambientes de riesgo:
- mascarillas FFP2/N95 o superiores
- guantes desechables
- protección ocular
🧪 DIAGNÓSTICO
El diagnóstico puede requerir:
- PCR molecular
- serología IgM/IgG
- TAC torácico
- radiografía pulmonar
- gasometría arterial
- hemograma
- pruebas de coagulación
💊 TRATAMIENTO
Actualmente:
- no existe tratamiento antiviral específico universalmente eficaz
- no existe vacuna ampliamente disponible para la mayoría de variantes
El tratamiento se basa en:
- oxigenoterapia
- ventilación mecánica
- soporte hemodinámico
- cuidados intensivos
El diagnóstico precoz mejora significativamente la supervivencia.
🌐 SITUACIÓN INTERNACIONAL 2026
En 2026 se han intensificado medidas preventivas internacionales tras investigaciones relacionadas con casos sospechosos en viajeros procedentes de Sudamérica.
España emitió protocolos preventivos institucionales relacionados con exposición potencial a hantavirus.
⚠️ CONCLUSIONES
- El hantavirus es una zoonosis potencialmente grave.
- El principal riesgo es ambiental y relacionado con roedores.
- La transmisión interpersonal es rara.
- La prevención depende de higiene ambiental y protección respiratoria.
- Ventilar espacios y evitar levantar polvo son medidas fundamentales.
- El diagnóstico precoz puede reducir significativamente la mortalidad.
🌍 FUENTES OFICIALES INTERNACIONALES
Organización Mundial de la Salud (OMS)
Centers for Disease Control and Prevention (CDC)
https://www.cdc.gov/hantavirus
European Centre for Disease Prevention and Control (ECDC)
https://www.ecdc.europa.eu/en/hantavirus
Ministerio de Sanidad de España
Public Health Agency of Canada
https://www.canada.ca/en/public-health/services/diseases/hantaviruses.html
NHS UK
📚 REFERENCIAS CIENTÍFICAS CON DOI REALES
Jonsson CB, Figueiredo LT, Vapalahti O.
A global perspective on hantavirus ecology, epidemiology, and disease.
Clinical Microbiology Reviews. 2010.
DOI: 10.1128/CMR.00062-09
https://doi.org/10.1128/CMR.00062-09
Kruger DH, Figueiredo LT, Song JW, Klempa B.
Hantaviruses—globally emerging pathogens.
DOI: 10.1128/CMR.00012-14
https://doi.org/10.1128/CMR.00012-14
Nichol ST et al.
Hantavirus pulmonary syndrome in the United States.
DOI: 10.1128/CMR.13.2.273
https://doi.org/10.1128/CMR.13.2.273
MacNeil A et al.
Sin Nombre virus infection in North America.
DOI: 10.1056/NEJMra1010289
https://doi.org/10.1056/NEJMra1010289
Vaheri A et al.
Hantavirus infections in Europe and their impact on public health.
DOI: 10.1016/S1473-3099(13)70167-3
https://doi.org/10.1016/S1473-3099(13)70167-3
Martínez-Valdebenito C et al.
Person-to-person household and nosocomial transmission of Andes hantavirus.
DOI: 10.1016/S0140-6736(14)60701-7
https://doi.org/10.1016/S0140-6736(14)60701-7
CDC Emerging Infectious Diseases Journal
Hantavirus Pulmonary Syndrome.
DOI: 10.3201/eid0107.950704
https://doi.org/10.3201/eid0107.950704
Schmaljohn C, Hjelle B.
Hantaviruses: a global disease problem.
DOI: 10.3201/eid0302.970202
https://doi.org/10.3201/eid0302.970202
Vapalahti O et al.
Hantavirus infections in Europe.
Lancet Infectious Diseases.
DOI: 10.1016/S1473-3099(03)00774-6
https://doi.org/10.1016/S1473-3099(03)00774-6
Hjelle B, Torres-Pérez F.
Hantaviruses in the Americas and their role as emerging pathogens.
Viruses.
DOI: 10.3390/v2030255
https://doi.org/10.3390/v2030255
By DrRamonReyesMD ⚕️
EL BROTE DE HANTAVIRUS DE MV HONDIUS DE 2026
Cronología, respuesta internacional, acciones del gobierno español y análisis operativo de salud pública.
Por el Dr. Ramón Reyes, MD ⚕️ | Actualizado: 6 de mayo de 2026 | Nivel DrRamonReyesMD
1. Resumen ejecutivo
Entre abril y mayo de 2026, se identificó un brote grave de enfermedad cardiopulmonar asociada al hantavirus entre los pasajeros y la tripulación del crucero de expedición MV Hondius , con bandera holandesa y operado por Oceanwide Expeditions. El barco había zarpado de Ushuaia, Argentina, el 1 de abril de 2026 , y tras navegar por zonas remotas del Atlántico Sur y subantárticas, se convirtió en el centro de una respuesta sanitaria internacional frente a las costas de Cabo Verde .
Según la Organización Mundial de la Salud (OMS) , al 4 de mayo de 2026 , fecha de su actualización sobre brotes de enfermedades, se habían identificado siete casos : dos infecciones por hantavirus confirmadas por laboratorio y cinco casos sospechosos , incluyendo tres fallecimientos , un paciente en estado crítico y tres personas con síntomas leves. El barco transportaba 147 pasajeros y tripulantes de 23 nacionalidades . La OMS evaluó el riesgo para la salud pública mundial como bajo , mientras continuaba investigando el origen, la dinámica de transmisión y la caracterización viral.
URL de la fuente: https://www.who.int/emergencies/disease-outbreak-news/item/2026-DON599
España se convirtió en un elemento central de la respuesta internacional el 5 de mayo de 2026 , cuando el Ministerio de Sanidad español anunció que España recibiría el MV Hondius en las Islas Canarias , tras una solicitud de la OMS en coordinación con la Unión Europea, en virtud del derecho internacional y los principios humanitarios. España declaró que Cabo Verde carecía de la capacidad suficiente para completar la operación y que las Islas Canarias eran el lugar más cercano con la infraestructura médica y de salud pública necesaria.
Fuente: https://www.sanidad.gob.es/gabinete/notasPrensa.do?id=6900
2. El vaso sanguíneo y el contexto epidemiológico
El MV Hondius es un crucero de expedición polar que opera en entornos marítimos remotos, como la Antártida, Georgia del Sur, Tristan da Cunha, Santa Elena y la Isla Ascensión. El viaje afectado atravesó zonas donde la exposición ambiental a fauna silvestre y reservorios de roedores es epidemiológicamente relevante. La OMS declaró que la fuente precisa de la exposición sigue bajo investigación y que el grado de contacto de los pasajeros con fauna silvestre o entornos contaminados antes o durante el viaje aún no se ha determinado.
Hantaviruses are zoonotic viruses primarily transmitted to humans through inhalation or contact with aerosolized urine, faeces or saliva of infected rodents. In the Americas, hantavirus cardiopulmonary syndrome can be severe and rapidly fatal. The Andes virus lineage is particularly important because, unlike most hantaviruses, limited human-to-human transmission has been documented in previous outbreaks, mainly after close and prolonged contact.
3. Chronology of Events
1 April 2026 — Departure from Argentina
The vessel departed Ushuaia, Argentina, on 1 April 2026. The itinerary included remote South Atlantic and sub-Antarctic locations: Antarctica, South Georgia, Nightingale Island, Tristan da Cunha, Saint Helena and Ascension Island.
6 April 2026 — First symptomatic case
The first described case was an adult male who developed fever, headache and mild diarrhoea on 6 April while aboard the ship.
11 April 2026 — First death onboard
By 11 April, the same passenger developed respiratory distress and died onboard. No microbiological testing was performed at that time.
24 April 2026 — Body removed at Saint Helena; close contact becomes ill
On 24 April, the deceased passenger’s body was removed from the vessel at Saint Helena, a British Overseas Territory. His close contact, an adult female, went ashore with gastrointestinal symptoms.
24–27 April 2026 — Further severe illness and medical evacuation
Another adult male presented to the ship’s doctor on 24 April with fever, shortness of breath and pneumonia. His condition worsened on 26 April, and he was medically evacuated from Ascension Island to South Africa on 27 April, where he was admitted to intensive care. PCR later confirmed hantavirus infection.
26 April 2026 — Second death in South Africa
The adult female close contact of the first fatal case deteriorated during travel to Johannesburg and died on arrival at the emergency department on 26 April. She was later confirmed by PCR as infected with hantavirus. Contact tracing for passengers on the flight was initiated.
2 May 2026 — WHO notification and laboratory confirmation
On 2 May, WHO received notification through the UK National International Health Regulations Focal Point of a cluster of severe acute respiratory illness aboard the Dutch-flagged cruise ship. South African laboratory testing confirmed hantavirus infection in the critically ill patient.
2 May 2026 — Third death onboard
An adult female with pneumonia died aboard the vessel on 2 May after onset of fever and malaise on 28 April.
3–4 May 2026 — Cluster recognized internationally
By 4 May, WHO reported seven cases: two laboratory-confirmed and five suspected, including three deaths. The vessel was moored off Cabo Verde.
5 May 2026 — Spain accepts the vessel
The Spanish Ministry of Health announced that Spain would receive the MV Hondius in the Canary Islands following a request from WHO and the European Union. Spain stated that passengers and crew would be examined, cared for and transferred to their countries under a common protocol developed by WHO and ECDC, using special spaces and transport to avoid contact with the local population and protect healthcare workers.
5 May 2026 — Spanish public health update
Spain reported six identified cases at that moment, two laboratory-confirmed, three deaths, one critically ill patient in South Africa and two persons still aboard. Spain also reported 147 people onboard from 23 nationalities, including 14 Spanish nationals: 13 passengers and one crew member. The Spanish Ministry assessed the risk to the Spanish general population as very low to extremely low.
Source URL: https://www.sanidad.gob.es/gabinete/notasPrensa.do?id=6899
6 May 2026 — Latest operational developments
By 6 May, Reuters reported that three people had been evacuated from the ship and that the vessel was expected to proceed toward Spain’s Canary Islands. Reuters also reported that eight cases had been linked to the outbreak, including a Swiss case, and that South Africa had identified the Andes strain in laboratory testing linked to the vessel.
4. Actions Taken by the Government of Spain
Spain’s response has included:
First, continuous coordination between the Spanish Ministry of Health, WHO, ECDC, the European Commission and involved countries. Spain explicitly framed the response under the International Health Regulations and EU Regulation 2022/2371 on serious cross-border threats to health.
Second, acceptance of the MV Hondius in the Canary Islands after WHO and EU request. Spain justified this on humanitarian grounds, international law and the presence of Spanish nationals onboard.
Third, preparation of a common case-and-contact management protocol with WHO and ECDC. Spain stated that passengers and crew would be examined, medically assisted and transferred to their respective countries under controlled conditions.
Fourth, medical transport planning. Spain announced that medical care and transfers would occur in specially designated spaces and transport systems to avoid contact with the local population and protect healthcare personnel.
Fifth, Spain accepted a formal request from the Netherlands to receive the ship’s physician, who was described as seriously ill and requiring medical air transport to the Canary Islands.
Sixth, risk communication. The Ministry emphasized that the risk for the Spanish population was very low and warned that misinformation on social media could create unnecessary alarm.
5. Actions by WHO, ECDC and International Authorities
WHO activated international coordination through IHR focal points involving Cabo Verde, the Netherlands, Spain, South Africa and the United Kingdom. WHO shared information globally with National IHR Focal Points and supported case isolation, medical evacuation, laboratory testing and epidemiological investigation.
ECDC stated on 5 May that the outbreak was under investigation and that the risk for Europe was very low. ECDC also monitored the outbreak from 4 May and coordinated with European and international partners.
Source URL: https://www.ecdc.europa.eu/en/news-events/hantavirus-outbreak-cruise-ship-under-investigation-risk-europe-very-low
South Africa’s National Institute for Communicable Diseases performed laboratory confirmation in at least one critically ill patient and contributed to viral characterization. WHO reported that serology, sequencing and metagenomics were ongoing.
The Institut Pasteur de Dakar, Senegal, was designated to receive additional laboratory samples from symptomatic passengers with WHO support.
Argentina shared passenger and crew lists through IHR channels according to nationality, supporting international contact tracing.
Cabo Verde allowed assessment activity but, according to Spain and media reports, was not considered capable of completing the full public health operation required for the vessel, which contributed to the request for Spain to receive the ship.
6. Clinical and Public Health Interpretation
The clinical syndrome described is consistent with hantavirus cardiopulmonary syndrome, characterized by an initial prodrome of fever, headache, myalgia and gastrointestinal symptoms, followed by abrupt pulmonary involvement, hypoxaemia, shock and possible death. WHO notes that symptoms typically develop 2–4 weeks after exposure, but may appear as early as one week and as late as eight weeks.
There is no approved specific antiviral treatment for hantavirus cardiopulmonary syndrome. Management is supportive and ICU-based: oxygenation, mechanical ventilation, haemodynamic monitoring, vasopressors, careful fluid strategy and, in severe cardiopulmonary failure, consideration of extracorporeal membrane oxygenation. Ribavirin has not demonstrated effectiveness for hantavirus cardiopulmonary syndrome and is not licensed for treatment or prophylaxis of HPS/HCPS.
The operational risk aboard a vessel differs from community risk. A cruise ship is a closed or semi-closed environment with shared air, shared surfaces, shared sanitation systems, prolonged close contact and logistical barriers to evacuation. Even when global risk is low, the operational risk to passengers, crew and responding medical teams requires structured isolation, active monitoring, controlled evacuation and specialized infection prevention and control.
7. What Is Confirmed and What Is Not Confirmed
Confirmed: a severe respiratory illness cluster occurred aboard the MV Hondius; WHO reported seven cases as of 4 May 2026, including two laboratory-confirmed hantavirus infections and three deaths; the vessel had 147 passengers and crew from 23 nationalities; Spain agreed to receive the vessel in the Canary Islands; WHO, ECDC, Spain, South Africa, Cabo Verde, the Netherlands and the United Kingdom were involved in the response.
Not fully confirmed as of this update: the exact original exposure source, whether infection occurred before boarding, during shore excursions or onboard, the precise chain of transmission, the final number of secondary infections, and the full genomic characterization of the virus. WHO explicitly stated that further investigations, sequencing and metagenomics were ongoing.
8. Core Public Health Lessons
The MV Hondius outbreak demonstrates that expedition tourism creates a unique interface between wilderness medicine, maritime medicine, infectious disease surveillance and international law. Remote cruise routes can delay diagnosis, complicate evacuation and distribute contacts across multiple jurisdictions before the outbreak is fully recognized.
The correct response is not panic. The correct response is disciplined epidemiology: early recognition, case isolation, laboratory confirmation, contact classification, safe evacuation, transparent risk communication, and strict infection prevention and control.
Spain’s role is operationally significant because it converted a floating multinational health problem into a coordinated public health intervention under WHO, ECDC and EU frameworks. The decision is controversial politically in the Canary Islands, but the medical logic is clear: unmanaged maritime infectious disease events require a port with sufficient ICU capacity, isolation capability, transport coordination, legal authority and international liaison.
9. Primary Sources, URLs and DOI
-
World Health Organization. Disease Outbreak News: Hantavirus cluster linked to cruise ship travel, Multi-country. 4 May 2026.
URL: https://www.who.int/emergencies/disease-outbreak-news/item/2026-DON599 -
European Centre for Disease Prevention and Control. Hantavirus outbreak on cruise ship under investigation: risk for Europe very low. 5 May 2026.
URL: https://www.ecdc.europa.eu/en/news-events/hantavirus-outbreak-cruise-ship-under-investigation-risk-europe-very-low -
Ministerio de Sanidad, Gobierno de España. España acogerá a la embarcación MV Hondius en las Islas Canarias en cumplimiento del Derecho Internacional y el espíritu humanitario. 5 May 2026.
URL: https://www.sanidad.gob.es/gabinete/notasPrensa.do?id=6900 -
Ministerio de Sanidad, Gobierno de España. Actualización de información disponible sobre el brote de hantavirus en el crucero de Países Bajos. 5 de mayo de 2026.
URL: https://www.sanidad.gob.es/gabinete/notasPrensa.do?id=6899 -
Ministerio de Sanidad, Gobierno de España. ¿Qué es el Hantavirus y qué se sabe de la infección en el crucero que viaja desde Argentina? 5 de mayo de 2026.
URL: https://www.sanidad.gob.es/gabinete/notasPrensa.do?id=6897 -
Oceanwide Expeditions. Actualización de prensa: cronograma actualizado de la situación médica a bordo del m/v Hondius. 5 de mayo de 2026.
URL: https://oceanwide-expeditions.com/blog/press-update-updated-timeline-of-the-medical-situation-on-board-mv-hondius-5-may-2026-15-30-cet -
Martínez VP, Di Paola N, Alonso DO, et al. “Superpropagadores” y transmisión de persona a persona del virus andino en Argentina. New England Journal of Medicine. 2020;383:2230–2241.
DOI: 10.1056/NEJMoa2009040
URL: https://www.nejm.org/doi/full/10.1056/NEJMoa2009040 -
OPS/OMS. Síndrome pulmonar por hantavirus: Alerta epidemiológica, Región de las Américas. 19 de diciembre de 2025.
URL: https://www.paho.org/en/documents/epidemiological-alert-hantavirus-pulmonary-syndrome-americas-region-19-december-2025
Declaración operativa final:
El brote de hantavirus ocurrido en el MV Hondius en 2026 no es simplemente un incidente en un crucero. Es una prueba en tiempo real de la gobernanza de las enfermedades infecciosas marítimas, la coordinación del RSI, los mecanismos de seguridad sanitaria de la UE, la gestión de riesgos del turismo de expedición y la logística de cuidados intensivos en entornos difíciles.
Por el Dr. Ramón Reyes, MD ⚕️
DrRamonReyesMD | Actualizado el 6 de mayo de 2026
